# Alcresta, Inc.

- Location (FDA's records): Newton, MA
- FDA decisions: 1 (2015–2015): 1 De Novo grant
- Product codes: PLQ (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Alcresta Therapeutics, Inc.: 3 (https://510kreport.com/company/alcresta-therapeutics)

## Its most-cited devices
- DEN150001: Relizorb (2015), cited by 3

## Recent decisions
- DEN150001: Relizorb (Nov 20, 2015)

Source page: https://510kreport.com/company/alcresta
